The Market Brief is a plain-English interpretation layer that compresses the day's most market-moving stories into short, readable summaries. It sits between the raw News Terminal and deeper analysis layers, providing editorial clarity without fabricating novelty. Each brief entry includes: a rewritten headline written for clarity (not sensationalism), the original source headline, a concise summary of the story, a plain-English impact note explaining why the story matters for markets, a market-angle label (rates, oil, equities, crypto, policy, or geopolitics), and the source link with publication timestamp. This layered approach is necessary because the same story often appears in multiple places with similar wording - this layer adds interpretive clarity while keeping full attribution visible.
The Market Brief is designed for traders, portfolio managers, and analysts who need to understand what happened and why it matters without reading full articles. It updates continuously as new stories arrive and are ranked for market relevance. The rewritten headlines help both human readers and AI agents understand market impact without clickbait or exaggeration. Each entry preserves the original source headline so readers can verify and dig deeper if needed.
Lead brief: Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy. Source: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight.